Ahead of RSNA 2022 in Chicago, Charles E. Kahn, Jr., MD, MS, spoke with Radiology Business about how AI is being used by radiologists—and how that may evolve in the years ahead.

The team will share its findings, based on imaging data from more than 5,000 pediatric patients, at RSNA 2022 in Chicago. 

The new study, published in JAMA Network Open, should help ease any concerns patients may have about regularly taking ADHD medications. 

The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022. 

Also worth a look: the ACR Data Science Institute’s AI Central, updated this week with detailed information on imaging AI products that have been cleared by the FDA.

When lung cancer is caught in its early stages, long-term survival rates can reach 80% and higher, according to a new large-scale, 20-year international study presented at this year's RSNA meeting.

VT storm is associated with a heightened risk of death or significant complications. Early catheter ablation, it seems, is the most effective treatment option for this potentially fatal condition. 

In a new analysis, scheduled to be presented at RSNA 2022 in Chicago, researchers have identified enlarged perivascular spaces in the brains of migraine patients. This may be suggestive of waste clearance issues in the central nervous system.